Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey. — CFSMEATLAS
Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey.
Holtzman, Carly S, Bhatia, Shaun, Cotler, Joseph et al. · Diagnostics (Basel, Switzerland) · 2019 · DOI
Quick Summary
This study worked directly with ME/CFS patients to create a better way to measure post-exertional malaise (PEM)—the symptom where activity makes you feel significantly worse. Over 1,500 patients completed a survey to help researchers understand what aspects of PEM are most important to measure, including what triggers it, how quickly symptoms start, and how long they last. The study shows that involving patients in designing assessment tools leads to more thorough and meaningful measurements.
Why It Matters
PEM is a core defining feature of ME/CFS, yet no gold-standard measurement tool existed. Better assessment of PEM is essential for research studies, clinical diagnosis, and helping doctors understand disease severity and progression. This patient-centered approach demonstrates that people living with ME/CFS possess critical insights that improve scientific measurement and ultimately clinical care.
Observed Findings
Over 1,534 ME/CFS patients participated in the survey, providing detailed information about their PEM experiences.
Patients identified multiple key domains of PEM, including specific triggers, timing of symptom onset after activity, and duration of symptom flares.
Existing PEM assessment tools had not comprehensively evaluated these domains in prior research.
Patient-driven input revealed aspects of PEM that researchers and clinicians might otherwise overlook.
Inferred Conclusions
Comprehensive PEM assessment requires evaluation of triggers, symptom onset timing, and duration as distinct domains.
Direct patient collaboration in symptom measurement tool development yields more complete and clinically relevant instruments.
Community-based participatory research is a valuable methodology for improving how ME/CFS symptoms are assessed.
Remaining Questions
Is the newly developed PEM survey valid and reliable when tested in different patient populations and clinical settings?
How do the identified PEM domains (triggers, onset, duration) correlate with objective biomarkers or physiological measures of post-exertional malaise?
Should the PEM assessment tool be modified or expanded based on demographic differences (age, disease duration, severity level) within the ME/CFS community?
What This Study Does Not Prove
This study does not prove that the newly developed PEM instrument is valid or reliable for clinical diagnosis—those properties require additional validation testing. It does not establish causation between specific triggers and PEM severity, nor does it identify the biological mechanisms underlying post-exertional malaise. The study describes what patients report about their symptoms but does not correlate these reports with objective physiological measures.